MicroRNAs in Soft Tissue Sarcomas: Overview of the Accumulating Evidence and Importance as Novel Biomarkers
Figure 1
Examples of clinical applications of miRNAs as biomarkers and therapeutics for patients with soft tissue sarcoma. As therapeutics: ① combination with neoadjuvant chemotherapy, ② combination with adjuvant chemotherapy, and ③ combination with chemotherapy for metastasis. As biomarkers: ❶ diagnosis, ❷ determination of drug resistance, ❸ monitoring after treatment for primary lesions, ❹ detection for micrometastasis, and ❺ monitoring after treatment for metastasis. ADR: adriamycin; IFO: ifosfamide; GEM: gemcitabine; DOC: docetaxel.